BioCryst Pharmaceuticals (BCRX) Interest Coverage Ratio: History & Chart

BioCryst Pharmaceuticals, Inc.(BCRX)

Biotechnology · Durham, NC

$8.15+0.05 (+0.62%)

Delayed quote: Oct 6, 2026, 9:30 AM EDT

About BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc. is a biotechnology company focused on discovering and developing novel, orally administered, small-molecule therapeutics. The company currently markets two key products: Peramivir injection: An intravenous neuraminidase inhibitor, sold under the brand names RAPIVAB, RAPIACTA, and PERAMIFLU, used for the treatment of acute uncomplicated influenza. ORLADEYO: An oral serine protease inhibitor designed to manage hereditary angioedema. BioCryst's development pipeline includes several promising candidates: BCX9930: An oral factor D inhibitor in Phase II clinical trials for complement-mediated diseases. BCX9250: An oral activin receptor-like kinase-2 inhibitor undergoing Phase I clinical evaluation for fibrodysplasia ossificans progressiva. Galidesivir: An RNA dependent-RNA polymerase inhibitor, also in Phase I, aimed at treating a range of RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika. The company engages in strategic collaborations and in-license agreements with numerous partners. These include pharmaceutical entities like Torii Pharmaceutical Co., Ltd., Seqirus UK Limited, Shionogi & Co., Ltd., Green Cross Corporation, and Mundipharma International Holdings Limited. Their alliances also extend to governmental and academic organizations such as the National Institute of Allergy and Infectious Diseases, the Biomedical Advanced Research and Development Authority, the U.S. Department of Health and Human Services, The University of Alabama at Birmingham, Albert Einstein College of Medicine of Yeshiva University, and Industrial Research, Ltd. Established in 1986, BioCryst Pharmaceuticals, Inc. is headquartered in Durham, North Carolina.

Durham, NC

435 employees

www.biocryst.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Charles K. Gayer

View full financials

BCRX Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

4.32x

INTEREST COVERAGE RATIO AVG TTM

-1.93x

INTEREST COVERAGE RATIO AVG 3Y

0.08x

INTEREST COVERAGE RATIO AVG 5Y

-0.80x

INTEREST COVERAGE RATIO AVG 10Y

-4.70x

INTEREST COVERAGE RATIO AVG 15Y

-5.94x

INTEREST COVERAGE RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

+324.29%

CURRENT VS 3Y AVG

+5372.15%

CURRENT VS 5Y AVG

+641.03%

CURRENT VS 10Y AVG

+191.95%

CURRENT VS 15Y AVG

+172.68%

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

-4.20x

median of 329 covered companies

CURRENT VS SECTOR MEDIAN

+202.86%

vs the sector median at left

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
BioCryst Pharmaceuticals, Inc. (BCRX)	$2.07B	4.32x	-1.93x	0.08x	-0.80x
Alvotech (ALVO)vs ›	$2.05B	0.52x	0.48x	0.48x	0.48x
Inspire Medical Systems, Inc. (INSP)vs ›	$2.06B	371.93x	1006.04x	1006.04x	1006.04x
Immunome, Inc. (IMNM)vs ›	$2.04B	N/A	N/A	N/A	N/A
Aurinia Pharmaceuticals Inc. (AUPH)vs ›	$2.03B	24.23x	24.23x	24.23x	24.23x
Addus HomeCare Corporation (ADUS)vs ›	$2.13B	14.46x	13.87x	10.91x	11.49x
Fortrea Holdings Inc. (FTRE)vs ›	$2.09B	-0.33x	467.98x	502.49x	502.49x
AxoGen, Inc. (AXGN)vs ›	$2.00B	-1.02x	0.38x	0.38x	0.21x
Azenta, Inc. (AZTA)vs ›	$2.01B	N/A	1.77x	2.62x	35.29x
Establishment Labs Holdings Inc. (ESTA)vs ›	$1.97B	-1.54x	N/A	N/A	N/A

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

BioCryst Pharmaceuticals, Inc. (BCRX)

$2.07B

4.32x

-1.93x

0.08x

-0.80x

Alvotech (ALVO)vs ›

$2.05B

0.52x

0.48x

Inspire Medical Systems, Inc. (INSP)vs ›

$2.06B

371.93x

1006.04x

Immunome, Inc. (IMNM)vs ›

$2.04B

N/A

Aurinia Pharmaceuticals Inc. (AUPH)vs ›

$2.03B

24.23x

Addus HomeCare Corporation (ADUS)vs ›

$2.13B

14.46x

13.87x

10.91x

11.49x

Fortrea Holdings Inc. (FTRE)vs ›

$2.09B

-0.33x

467.98x

502.49x

AxoGen, Inc. (AXGN)vs ›

$2.00B

-1.02x

0.38x

0.21x

Azenta, Inc. (AZTA)vs ›

$2.01B

N/A

1.77x

2.62x

35.29x

Establishment Labs Holdings Inc. (ESTA)vs ›

$1.97B

-1.54x

N/A

Interest Coverage Ratio FAQ

What is the interest coverage ratio for BioCryst Pharmaceuticals, Inc. (BCRX)?

The interest coverage ratio for BCRX stock is 4.32x.

Is BioCryst Pharmaceuticals, Inc.'s interest coverage ratio high or low?

The interest coverage ratio of 4.32x is 641% above its 5-year average of -0.80x, near the high end of its 5-year range (-35.47x–18.42x).

What is the TTM average interest coverage ratio for BioCryst Pharmaceuticals, Inc. (BCRX)?

The TTM average interest coverage ratio for BCRX stock is -1.93x.

What is the 3Y average interest coverage ratio for BioCryst Pharmaceuticals, Inc. (BCRX)?

The 3Y average interest coverage ratio for BCRX stock is 0.08x.

What is the 5Y average interest coverage ratio for BioCryst Pharmaceuticals, Inc. (BCRX)?

The 5Y average interest coverage ratio for BCRX stock is -0.80x.

What is the 10Y average interest coverage ratio for BioCryst Pharmaceuticals, Inc. (BCRX)?

The 10Y average interest coverage ratio for BCRX stock is -4.70x.

What is the 15Y average interest coverage ratio for BioCryst Pharmaceuticals, Inc. (BCRX)?

The 15Y average interest coverage ratio for BCRX stock is -5.94x.

DATE	INTEREST COVERAGE RATIO
2026-06-30	4.54x
2026-03-31	-35.47x
2025-12-31	18.42x
2025-09-30	1.51x
2025-06-30	1.38x
2025-03-31	0.90x
2024-12-31	-0.18x
2024-09-30	0.31x
2024-06-30	0.35x
2024-03-31	-0.59x
2023-12-31	-1.74x
2023-09-30	-0.44x
2023-06-30	-0.72x
2023-03-31	-1.04x
2022-12-31	-1.75x
2022-09-30	-0.70x
2022-06-30	-1.45x
2022-03-31	-2.10x
2021-12-31	-2.78x
2021-09-30	-3.16x
2021-06-30	-2.19x
2021-03-31	-3.98x
2020-12-31	-9.34x
2020-09-30	-13.23x
2020-06-30	-13.20x
2020-03-31	-13.45x
2019-12-31	-0.04x
2019-09-30	-11.53x
2019-06-30	-11.51x
2019-03-31	-10.76x
2018-12-31	-10.46x
2018-09-30	-12.15x
2018-06-30	-8.31x
2018-03-31	-10.00x
2017-12-31	-8.01x
2017-09-30	-6.24x
2017-06-30	-7.41x
2017-03-31	-5.09x
2016-12-31	-3.84x
2016-09-30	-6.31x
2016-06-30	-8.54x
2016-03-31	-12.96x
2015-12-31	-12.85x
2015-09-30	-10.61x
2015-06-30	4.09x
2015-03-31	-10.97x
2014-12-31	-11.53x
2014-09-30	-9.54x
2014-06-30	-9.48x
2014-03-31	-5.95x
2013-12-31	-5.10x
2013-09-30	-5.81x
2013-06-30	-10.42x
2013-03-31	-4.51x
2012-12-31	-9.06x
2012-09-30	-6.87x
2012-06-30	-8.77x
2012-03-31	-4.31x
2011-12-31	-9.52x
2011-09-30	-11.04x
2011-06-30	-12.22x
2011-03-31	-39.93x

DATE

INTEREST COVERAGE RATIO

2026-06-30

4.54x

2026-03-31

-35.47x

2025-12-31

18.42x

2025-09-30

1.51x

2025-06-30

1.38x

2025-03-31

0.90x

2024-12-31

-0.18x

2024-09-30

0.31x

2024-06-30

0.35x

2024-03-31

-0.59x

2023-12-31

-1.74x

2023-09-30

-0.44x

2023-06-30

-0.72x

2023-03-31

-1.04x

2022-12-31

-1.75x

2022-09-30

-0.70x

2022-06-30

-1.45x

2022-03-31

-2.10x

2021-12-31

-2.78x

2021-09-30

-3.16x

2021-06-30

-2.19x

2021-03-31

-3.98x

2020-12-31

-9.34x

2020-09-30

-13.23x

2020-06-30

-13.20x

2020-03-31

-13.45x

2019-12-31

-0.04x

2019-09-30

-11.53x

2019-06-30

-11.51x

2019-03-31

-10.76x

2018-12-31

-10.46x

2018-09-30

-12.15x

2018-06-30

-8.31x

2018-03-31

-10.00x

2017-12-31

-8.01x

2017-09-30

-6.24x

2017-06-30

-7.41x

2017-03-31

-5.09x

2016-12-31

-3.84x

2016-09-30

-6.31x

2016-06-30

-8.54x

2016-03-31

-12.96x

2015-12-31

-12.85x

2015-09-30

-10.61x

2015-06-30

4.09x

2015-03-31

-10.97x

2014-12-31

-11.53x

2014-09-30

-9.54x

2014-06-30

-9.48x

2014-03-31

-5.95x

2013-12-31

-5.10x

2013-09-30

-5.81x

2013-06-30

-10.42x

2013-03-31

-4.51x

2012-12-31

-9.06x

2012-09-30

-6.87x

2012-06-30

-8.77x

2012-03-31

-4.31x

2011-12-31

-9.52x

2011-09-30

-11.04x

2011-06-30

-12.22x

2011-03-31

-39.93x

Interest Coverage Ratio: 4.32x

BCRX Interest Coverage Ratio

BCRX Average Interest Coverage Ratio Chart

BCRX Current vs Average Interest Coverage Ratio Chart

BCRX Interest Coverage Ratio Metrics

BCRX Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Interest Coverage Ratio FAQ

BCRX Interest Coverage Ratio History

Related Metrics